Published in Int J Clin Exp Pathol on January 01, 2015
Cancer of the ovary. N Engl J Med (2004) 11.21
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature (2000) 10.04
Role of angiogenesis in tumor growth and metastasis. Semin Oncol (2002) 9.77
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol (2002) 6.51
Ovarian cancer development and metastasis. Am J Pathol (2010) 5.92
A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods (1994) 5.34
The anthracyclines: will we ever find a better doxorubicin? Semin Oncol (1992) 3.28
Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res (1997) 2.32
Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci (2006) 2.00
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett (2002) 1.72
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51
The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. Anticancer Drugs (2004) 1.35
Uracil-tegafur in gastric carcinoma: a comprehensive review. J Clin Oncol (1998) 1.31
A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma. J Clin Oncol (1986) 1.25
Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer (1997) 1.23
Betulinic acid-induced apoptosis in leukemia cells. Leukemia (2004) 1.09
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer (1980) 1.00
Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol (1986) 0.95
Betulinic acid and its derivatives as anti-angiogenic agents. Bioorg Med Chem Lett (2004) 0.93
Gene expression analysis of murine cells producing amphotropic mouse leukaemia virus at a cultivation temperature of 32 and 37 degrees C. J Gen Virol (2003) 0.92
Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn J Cancer Res (2002) 0.91
New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships. J Med Chem (2003) 0.89
Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma. Am J Obstet Gynecol (1984) 0.89
Postoperative radiation therapy for epithelial ovarian cancer: the curative role based on a 24-year experience. J Clin Oncol (1985) 0.87
Radiotherapeutic management of ovarian cancer. Semin Oncol (1984) 0.86
Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma. Arch Gynecol Obstet (2008) 0.84
External radiotherapy of ovarian cancer: standard approaches and new frontiers. Semin Oncol (1975) 0.82